home · filing · 0001125376-22-000153
8-K
filed December 22, 2022, 6:59 PM ET
ticker ENSG
CIK 0001125376
leadership
confidence high
sentiment neutral
materiality 0.40
Ensign Group appoints John Agwunobi to board; Lee Daniels resigns Jan 1, 2023
ENSIGN GROUP, INC
Lee Daniels resigns effective Jan 1, 2023 after serving since 2013; was Compensation Committee Chair.
John O. Agwunobi appointed to board effective Jan 1, 2023; term ends at 2023 annual meeting.
Agwunobi joins Quality & Assurance and Audit Committees; Swati Abbott named Compensation Committee Chair.
Agwunobi formerly CEO of Herbalife, President of Walmart Health & Wellness, HHS Assistant Secretary.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Departed
Lee A. Daniels
Director
Effective 2023-01-01
Successor John O. Agwunobi
Filed December 22, 2022, 6:59 PM ET
Lee A. Daniels announced his decision to resign from the Board effective on January 1, 2023 to focus on other endeavors.
Appointed
John O. Agwunobi
Director
Effective 2023-01-01
Filed December 22, 2022, 6:59 PM ET
the Board appointed John O. Agwunobi, M.D., to fill the vacancy created by Mr. Daniel’s resignation.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 1.0
Lee A. Daniels resigned as Director at ENSIGN GROUP, INC.
Action resigned
Role Director
Exact text from the filing
Lee A. Daniels announced his decision to resign from the Board effective on January 1, 2023 to focus on other endeavors.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
John O. Agwunobi was appointed as Director at ENSIGN GROUP, INC.
Action appointed
Role Director
Exact text from the filing
the Board appointed John O. Agwunobi, M.D., to fill the vacancy created by Mr. Daniel’s resignation.
View on SEC.gov
Source: SEC EDGAR
accession 0001125376-22-000153
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.